Nexentis Technologies (NXTS) files for 2.57M share offering by selling stockholders Jul 13, 2026 04:08PM
Nexentis partially monetizes Melz solar project at $14.5M valuation Jun 29, 2026 08:20AM
MitoCareX Bio partners with Boltz on AI-driven SLC drug discovery Jun 22, 2026 08:23AM
MitoCareX Bio completes SLC transport protein structural analysis Jun 17, 2026 07:33AM
Nexentis unit achieves drug discovery milestone with improved molecule May 18, 2026 09:34AM


May 18, 2026 09:31AM Nexentis subsidiary hits drug discovery milestone for cancer treatment
May 13, 2026 07:07AM Nexentis subsidiary achieves drug discovery milestone
May 5, 2026 07:32AM Nexentis receives U.S. trademark registration for MITOLINE algorithm
Apr 16, 2026 04:18PM Nexentis Technologies (NXTS) files $100M mixed shelf